This Randomised Control Trial (RCT) aims to test a novel Alopecia-tailored, protocolled, integrative individual psychological intervention offered to patients with enduring Alopecia. The pilot study aims to assess the impact of the intervention on 8 patients, by assessing changes in their psychological and physical symptoms (stress, anxiety, depression, quality of life, scalp hair, and other bio-markers) compared to 7 patients in the wait-list control group.
Alopecia is a stress-related auto-immune skin condition that results in hair-loss on the scalp and around the body. This pilot RCT aims to test a newly developed Alopecia-specific, psychological intervention with 8 patients diagnosed with enduring Alopecia. The intervention is an Integrative Cognitive Behavioural Therapy, implemented through a protocolled programme entailing 12 weeks of hourly individual sessions. The trial will be delivered at The Dermatology Department at the Royal Free Hospital in Hampstead, London. The pilot study aims to evaluate the impact of the intervention on patients' psychological and physical symptoms (stress, anxiety, depression, quality of life, scalp hair, and other bio-markers) compared to the wait-list control group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
15
This intervention involves the psychological intervention of Cognitive Behavioural Therapy. This intervention also includes third wave psychological interventions of Mindfulness and Narrative Therapy which has been found to be helpful for people with chronic health conditions and chronic skin conditions.
Royal Free Hospital
London, United Kingdom
Hospital Anxiety And Depression Scale (HADS)
Psychological Measure: Self-reported questionnaire assessing anxiety and depressive symptoms
Time frame: 12 weeks
Perceived Stress Scale (PSS)
Psychological Measure: Self-reported questionnaire measuring perceived stress
Time frame: 12 weeks
Dermatology Life Quality Index (DLQI)
Psychological Measure: Self-reported questionnaire measuring impact of Alopecia on participants quality of life
Time frame: 12 weeks
Severity of Alopecia Tool (SALT) Scalp Assessment
Physical Measure: Percentage of total hair loss
Time frame: 12 weeks
Blood Test
Physical Measure: Thyroid Stimulating Hormone Serum (Munit/ L) and Ferritin Serum (Micrograms)
Time frame: 12 weeks
Physical Measures
Medical Photography
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.